| Not Yet Recruiting | A Study of HS-10566 in Patients With High-risk Non-muscle-invasive Bladder Cancer Who Are Ineligible for or Re High-risk Non-muscle-invasive Bladder Cancer | Phase 1 / Phase 2 | 2026-06-10 |
| Not Yet Recruiting | A Study of HS-20136-2 in Healthy Participants Healthy | Phase 1 | 2026-05-15 |
| Not Yet Recruiting | A Phase I Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HS-10506 in Healthy Chinese Healthy Participants | Phase 1 | 2026-04-30 |
| Not Yet Recruiting | Phase 1 Study of HS-20152 in Healthy Participants Healthy Volunteers | Phase 1 | 2026-04-22 |
| Not Yet Recruiting | A Phase Ib Study of HS-10504 Combined Therapy in NSCLC Lung Cancer | Phase 1 | 2026-03-30 |
| Not Yet Recruiting | Efficacy and Safety Study of HS-10542 for IgA Nephropathy IgAN, Immunoglobulin A Nephropathy (IgAN), Glomerular Disease | Phase 2 | 2026-03-17 |
| Recruiting | Study of Safety and Efficacy of HS-10542 in Patients With Paroxysmal Nocturnal Hemoglobinuria Paroxysmal Nocturnal Hemoglobinuria | Phase 1 / Phase 2 | 2026-02-14 |
| Not Yet Recruiting | A Phase 3 Study of HS-20094 in Patients With T2DM Inadequately Controlled With Diet and Exercise Alone Type 2 Diabetes | Phase 3 | 2025-09-30 |
| Not Yet Recruiting | A Phase 3 Study of HS-20094 in Patients With T2DM Type 2 Diabetes | Phase 3 | 2025-09-30 |
| Recruiting | A Study of HS-10504 in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC) Locally Advanced or Metastatic NSCLC | Phase 1 | 2025-07-22 |
| Recruiting | Study of HS-10516 Combination Therapy in Patients With Advanced Renal Cell Carcinoma Advanced Clear Cell Renal Cell Carcinoma | Phase 1 / Phase 2 | 2025-07-10 |
| Not Yet Recruiting | A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HS-10510 in Healthy Subj Dyslipidemia | Phase 1 | 2025-06-01 |
| Not Yet Recruiting | A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors Advanced Solid Tumors, Colorectal Cancer, Non-Small Cell Lung Cancer | Phase 1 | 2025-05-30 |
| Recruiting | HS-10542 Study in Healthy Participants Healthy | Phase 1 | 2025-05-16 |
| Recruiting | Evaluate the Safety and Pharmacokinetics/Pharmacodynamics and Food Effect of HS-20118 Psoriasis | Phase 1 | 2025-05-16 |
| Not Yet Recruiting | A Study of HS-10529 in KRAS G12D Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2025-05-15 |
| Recruiting | HS-10502 Combination Treatment in Patients With Advanced Solid Tumors Recurrent Ovarian Cancer, HER2-negative, Advanced Breast Cancer | Phase 1 | 2025-05-07 |
| Recruiting | Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118 Psoriasis | Phase 1 | 2025-05-02 |
| Recruiting | A Study of HS-20094 in Overweight or Obese Participants Overweight or Obesity | Phase 1 | 2025-04-16 |
| Not Yet Recruiting | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HS-10561 Capsule in Chronic Spontaneous Urticaria | Phase 1 / Phase 2 | 2025-03-31 |
| Not Yet Recruiting | Pharmacokinetic Study of HS-10365 Capsule in Subjects with Hepatic Impairment and Normal Hepatic Function NSCLC (advanced Non-small Cell Lung Cancer) | Phase 1 | 2025-02-28 |
| Not Yet Recruiting | Pharmacokinetic Study of HS-10241 Tablets in Subjects with Hepatic Impairment and Normal Hepatic Function Advanced Non-small Cell Lung Cancer | Phase 1 | 2025-02-28 |
| Recruiting | A Study Evaluating the Effect of Aumolertinib on the Pharmacokinetics of Midazolam in Patients With NSCLC Non Small Cell Lung Cancer | Phase 1 | 2025-02-20 |
| Recruiting | A Study of Aumolertinib in European Participants With Non-Small Cell Lung Cancer Non-Small Cell Lung Cancer | Phase 1 | 2024-12-05 |
| Recruiting | A Study of HS-20094 in Chinese Adults with Overweight or Obesity Overweight, Obesity | Phase 3 | 2024-11-11 |
| Not Yet Recruiting | A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Participants with KRAS G12C Mutatio Non-Small Cell Lung Cancer, Advanced Solid Tumors | Phase 1 | 2024-10-31 |
| Not Yet Recruiting | A Study Evaluating Food Effect on Pharmacokinetics of HS-10518 Endometriosis | Phase 1 | 2024-08-15 |
| Completed | Evaluating the Efficacy and Safety of Intra-articular Injection of HS-20116 in Patients With Knee Osteoarthrit Knee Osteoarthritis | Phase 3 | 2024-08-13 |
| Not Yet Recruiting | Study of HS-10382 Combination in Patients With Chronic Myeloid Leukemia (CML) Chronic Myelogenous Leukemia, CML Chronic Phase, CML Accelerated Phase | Phase 1 | 2024-07-31 |
| Recruiting | A Study of HS-10516 in Patients With VHL Syndrome Associated Tumors Von Hippel Lindau-Deficient Clear Cell Renal Cell Carcinoma | Phase 1 | 2024-07-19 |
| Not Yet Recruiting | Phase 1 Study in Healthy Participants and Participants With Kidney Dysfunction Healthy | Phase 1 | 2024-05-31 |
| Unknown | Phase Ⅰb/Ⅱ Study of HS-10506 in Chinese Participants With Insomnia Disorder Insomnia Disorder | Phase 1 / Phase 2 | 2024-05-01 |
| Recruiting | A Study of HS-10501 Tablets in Healthy Subjects Healthy Subjects | Phase 1 | 2024-03-14 |
| Not Yet Recruiting | A Study of HS-10383 in Chinese Adult Subjects With Refractory or Unexplained Chronic Cough (RUCC) Cough | Phase 2 | 2024-03-01 |
| Unknown | The Phase I Study of HS-10509 in Chinese Adult Subjects Schizophrenia | Phase 1 | 2024-03-01 |
| Completed | A Study of HS-20094 in Patients With T2DM Type 2 Diabetes | Phase 2 | 2024-02-06 |
| Unknown | A Trial of HS-10511 in Healthy Subjects Hypertrophic Cardiomyopathy | Phase 1 | 2024-01-31 |
| Unknown | A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSC Non-Small Cell Lung Cancer | Phase 3 | 2023-12-30 |
| Unknown | A Study of HS-10518 in Healthy Female Participants Endometriosis | Phase 1 | 2023-11-01 |
| Unknown | A Study of HS-20094 Evaluating Weight Loss in Obese and Overweight Chinese Subjects Overweight and Obesity | Phase 2 | 2023-10-16 |
| Recruiting | A Study of HS-10365 in Patients With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer Nonsmall Cell Lung Cancer | Phase 2 | 2023-09-25 |
| Unknown | A Study of HS-10516 in Patients With Advanced Clear Cell Renal Cell Carcinoma Renal Cell Carcinoma | Phase 1 | 2023-09-25 |
| Unknown | A Study of HS-10353 in Adult Participants With Major Depressive Disorder Major Depressive Disorder (MDD) | Phase 2 | 2023-08-31 |
| Unknown | A Phase II Study of HS-10353 in Participants With Postpartum Depression Postpartum Depression | Phase 2 | 2023-08-31 |
| Unknown | Safety, Tolerability, Pharmacokinetics and Efficacy Study of HS-10380 in Patients With Schizophrenia Schizophrenia | Phase 1 / Phase 2 | 2023-07-30 |
| Unknown | Phase 1a Study in Healthy Participants Healthy | Phase 1 | 2023-07-17 |
| Unknown | A Multiple-Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of HS-10383 Cough | Phase 1 | 2023-06-14 |
| Recruiting | A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors Ovarian Cancer, Breast Cancer, Pancreatic Cancer | Phase 1 | 2023-06-09 |
| Completed | A Study of HS-20094 in T2DM Participants Type 2 Diabetes | Phase 2 | 2023-05-31 |
| Unknown | Comparing of the PK, PD, Safety and Immunogenicity of HS-20090 and Xgeva® in Healthy Adults Healthy | Phase 1 | 2023-04-20 |
| Recruiting | A Phase I Study of HS-10386 in Participants With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2023-03-02 |
| Unknown | Study of HS-10517 in Chinese Adult Participants COVID-19 | Phase 1 / Phase 2 | 2023-02-01 |
| Unknown | A Study of HS-10380 in Chinese Participants Schizophrenia | Phase 1 | 2022-08-01 |
| Unknown | A PhaseⅠStudy of HS-10381 in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2022-06-08 |
| Recruiting | Phase 1/2 Study of HS-10370 in Patients with Advanced Solid Tumors Advanced Solid Tumor | Phase 1 / Phase 2 | 2022-06-03 |
| Not Yet Recruiting | A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed C CML, Chronic Phase | Phase 4 | 2022-04-30 |
| Recruiting | A Study of HS-10382 in Patients With Chronic Myeloid Leukemia. CML, Chronic Phase, CML, Accelerated Phase | Phase 1 | 2022-04-28 |
| Active Not Recruiting | Long-term Safety and Efficacy of Tenofovir Amibufenamide in Patients With CHB Hepatitis B, Chronic | Phase 4 | 2022-03-10 |
| Recruiting | Phase 1/2 Study of HS-10375 in Patients with Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC) Advanced or Metastatic NSCLC | Phase 1 / Phase 2 | 2022-03-02 |
| Unknown | First-in-Human Study to Investigate the Safety and Tolerability and Pharmacokinetics of HS-10383 Cough | Phase 1 | 2022-03-01 |
| Unknown | A Phase Ib Study of HS-10352 Plus Fulvestrant in Patients With Advanced Breast Cancer Breast Cancer | Phase 1 | 2022-01-12 |
| Unknown | Study of HS-10241 in Combination With Almonertinib in Patients With Locally Advanced or Metastatic NSCLC Non Small Cell Lung Cancer | Phase 1 | 2022-01-05 |
| Unknown | A Study of the Efficacy and Safety of Flumatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in CML, Chronic Phase | Phase 4 | 2021-11-23 |
| Completed | A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10374 in Healthy Subjects Psoriasis | Phase 1 | 2021-11-13 |
| Unknown | Phase Ⅰ/Ⅱ Study of the HS-10365 in Patients With Advanced Solid Tumors Solid Tumor | Phase 1 / Phase 2 | 2021-11-09 |
| Unknown | A Study of HS-20094 in Healthy Participants Type 2 Diabetes | Phase 1 | 2021-11-01 |
| Completed | A Study To Evaluate The Safety, Tolerability And Pharmacokinetics of HS-10345 In Treatment-Resistant Depressio Treatment Resistant Depressive Disorder | Phase 1 | 2021-10-28 |
| Unknown | Phase 1/2 Study of HS-10376 in Patients With Non-Small Cell Lung Cancer Advanced Non-Small-Cell Lung Cancer | Phase 1 / Phase 2 | 2021-09-30 |
| Unknown | A Study of HS-10342 in Chinese Patients With HR+/HER2- Advanced and/or Metastatic Breast Cancer HR+/HER2- Advanced and/or Metastatic Breast Cancer | Phase 2 | 2021-09-30 |
| Active Not Recruiting | Aumolertinib with or Without Chemotherapy As 1st Line Treatment in Locally Advanced or Metastatic Non-Small Ce Non-small Cell Lung Cancer | Phase 3 | 2021-08-11 |
| Unknown | A Phase III Study to Assess the Efficacy and Safety of Almonertinib Versus Platinum-based Chemotherapy as Firs Non-small Cell Lung Cancer | Phase 3 | 2021-07-15 |
| Unknown | Phase I Study to Evaluate Safety, Tolerability, and Pharmacokinetics of HS-10360 in Healthy Subjects. Healthy | Phase 1 | 2021-07-01 |
| Active Not Recruiting | Almonertinib Versus Placebo as Adjuvant Therapy in Resected Stage II-IIIB Non-Small Cell Lung Cancer With EGFR Non-small Cell Lung Cancer | Phase 3 | 2021-04-30 |
| Recruiting | A Phase III Study to Assess the Effects of Almonertinib Following Chemoradiation in Patients With Stage III Un Non-small Cell Lung Cancer | Phase 3 | 2021-03-18 |
| Unknown | Evaluation of Clinical Equivalence Between Two Linaclotide Products in the Treatment of Chronic Idiopathic Con Chronic Idiopathic Constipation | Phase 3 | 2021-03-05 |
| Completed | A Study of HS-10353 in Chinese Participants. Major Depressive Disorder | Phase 1 | 2021-01-27 |
| Completed | Bioequivalence of Dapagliflozin 10 mg Tablets Under Fasting Conditions Healthy Subjects | Phase 1 | 2020-12-14 |
| Completed | Bioequivalence of Dapagliflozin 10 mg Tablets Under Fed Conditions Healthy Subjects | Phase 1 | 2020-12-10 |
| Unknown | Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Administration of HS-10356 in Healthy Vo Healthy | Phase 1 | 2020-12-01 |
| Unknown | Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Breast Cancer | Phase 1 | 2020-09-08 |
| Unknown | Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of HS-20090 and Xgeva® in Healthy Bone Metastasis From Solid Tumors | Phase 1 | 2020-09-01 |
| Completed | Evaluation of Drug Interaction Between HS-10234 and Emtriccitabine Healthy Subjects | Phase 1 | 2020-08-03 |
| Unknown | PhaseⅠStudy of the HS-10241 in Patients With Advanced Solid Tumors Solid Tumor | Phase 1 | 2019-06-21 |
| Unknown | Study of the Efficacy and Safety of Pegol-Sihematide for Anemia in Patients With NDD-CKD Non-Dialysis-Dependent Chronic Kidney Disease | Phase 3 | 2019-06-20 |
| Completed | A Study of HS-10342 in Patients With Advanced Solid Tumor Advanced Solid Tumor | Phase 1 | 2019-06-19 |
| Completed | Study of the Efficacy and Safety of Pegol-Sihematide for Anemia in Patients With Chronic Kidney Disease on Dia Chronic Kidney Diseases | Phase 3 | 2019-05-15 |
| Unknown | A Study to Evaluate Safety and Efficacy of HS-10296 as First-Line Treatment in Patients Non Small Cell Lung Cancer | Phase 3 | 2019-02-01 |
| Completed | Study of the Efficacy and Safety of HS-10234 in Patients With Chronic Hepatitis B Virus Infection Chronic HBV Infection | Phase 3 | 2018-08-16 |
| Unknown | Tolerability, Safety, Pharmacokinetics and Efficacy of HS-10241 Single Agent or Combined With Apatinib in Pati Advanced Cancer | Phase 1 | 2017-08-08 |
| Unknown | A Study to Evaluate Safety, PK and Efficacy of HS-10296 in Patients With NSCLC Nonsmall Cell Lung Cancer | Phase 1 / Phase 2 | 2017-05-08 |
| Unknown | A Trial of C-met Kinase Inhibitor HS-10241 in Subjects With Advanced Solid Tumours Carcinoma, Solid Tumor, Adult | Phase 1 | 2016-11-01 |
| Unknown | A Trial to Assess the Efficacy and Safety of Morinidazole in Women With Pelvic Inflammatory Disease Pelvic Inflammatory Disease | Phase 4 | 2016-09-01 |
| Unknown | A Trial to Assess the Efficacy and Safety of Morinidazole in Patients With Appendicitis Appendicitis | Phase 4 | 2016-09-01 |
| Unknown | Tolerability to HS-20004 With Titration Administration in Type 2 Diabetic Patients Diabetes Mellitus, Type 2 | Phase 1 | 2015-12-01 |
| Unknown | Safety & Efficacy of Pegolsihematide for Treatment of Anemia in Participants on Dialysis Chronic Renal Failure, Anemia, Dialysis | Phase 2 | 2015-10-01 |
| Completed | Evaluate the Pharmacokinetics of Warfarin When Coadministered With PEX168 in Healthy Adult Subjects Healthy | Phase 1 | 2015-08-01 |
| Completed | Evaluate the Pharmacokinetics of Digoxin When Coadministered With PEX168 in Healthy Adult Subjects Healthy | Phase 1 | 2015-06-08 |
| Completed | Evaluate the Pharmacokinetics of Simvastatin When Coadministered With PEX168 in Healthy Adult Subjects Type 2 Diabetes Mellitus | Phase 1 | 2015-03-30 |
| Unknown | Polyethylene Glycol Loxenatide Pharmacokinetics Study in Subjects With Normal and Insufficiency Renal Function Type 2 Diabetes Mellitus | Phase 1 | 2015-02-01 |
| Unknown | Phase I Trial to Investigate Cafusertib Hydrochloride Monotherapy in Chinese Patients With Advanced Solid Tumo Neoplasms | Phase 1 | 2014-11-01 |
| Completed | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple s.c Doses HS-20004 in Healthy Chinese Healthy | Phase 1 | 2014-10-01 |
| Unknown | Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With ERSD Receiving Maintenance Hemo Chronic Renal Failure, Anemia | Phase 2 | 2014-07-01 |
| Completed | The Study of the Efficacy and the Safety of Flumatinib vs Imatinib as First Line Treatment in Patients With CM CML, CML-CP,MMR,TKI | Phase 3 | 2014-06-01 |
| Unknown | Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With Chronic Kidney Diseases Not on Chronic Renal Failure, Chronic Kidney Disease, Anemia | Phase 2 | 2014-06-01 |
| Unknown | Safety & Pharmacokinetics of Pegolsihematide for Treatment of Anemia Patient With Myelodysplastic Syndromes Myelodysplastic Syndromes, Anemia | Phase 1 | 2014-06-01 |
| Unknown | Phase I Trial to Investigate Cafusertib Hydrochloride in Combination With Low Dose Cytarabine in Chinese Patie Leukemia, Myeloid, Acute | Phase 1 | 2014-05-01 |
| Unknown | Efficacy and Safety Study of PEX168 in Monotherapy Diabetes Mellitus Type 2 Patients Type 2 Diabetes Mellitus | Phase 3 | 2014-03-23 |
| Unknown | Efficacy and Safety Study of PEX168 in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin Type 2 Diabetes Mellitus | Phase 3 | 2014-02-27 |
| Unknown | A Study of Sustained-Release Desvenlafaxine Hydrochloride for the Treatment of Major Depressive Disorder Major Depressive Disorder | Phase 2 / Phase 3 | 2013-10-01 |
| Unknown | A Phase Ⅰa Study of Azilsartan Trimethylethanolamine in Healthy Volunteers Health | Phase 1 | 2013-09-01 |
| Unknown | Phase Ⅲ Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg-positive Chronic Hepatitis B Hepatitis B, Chronic | Phase 3 | 2013-08-01 |
| Unknown | A Phase II Study to Evaluate the Efficacy and the Safety of Flumatinib in CML-AP or CML-BP Patients Chronic Myelogenous Leukemia | Phase 2 | 2013-01-01 |
| Completed | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HS-20004 in Healthy Chinese Volunteers Healthy | Phase 1 | 2012-12-01 |
| Completed | Efficacy and Safety Study of Iloperidone Virus Risperidone to Treat Schizophrenia Schizophrenia, Iloperidone, Efficacy | Phase 2 | 2012-06-01 |
| Completed | Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis B Hepatitis B, Chronic | Phase 2 | 2011-05-01 |